Product Specification
Packaging Size | Single |
Brand | Epofit |
Manufacturer | Intas Pharmaceuticals Ltd |
Composition | Erythropoietin 5000 IU |
Treatment | chronic kidney failure |
Prescription/Non prescription | Non prescription |
Medicine Type | Injection |
Product Description
Erythropoietin 5000 IU.
This medication is a haematopoietic agent, prescribed for anemia in people with chronic kidney failure. It helps in the formation of red blood cells by the bone marrow.
Erythropoietin is indicated for the treatment of-
- Anemia associated with Chronic Renal Failure, including patients on dialysis and patients not on dialysis.
- Anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.
- Anemic patients (hemoglobin >10 to <13 g/dL) are scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions.
- Anemia related to therapy with zidovudine in HIV-infected patients.
Description
Erythropoietin (EPO) is a glycoprotein hormone, which is the primary regulator of red blood cell formation in mammals. Recombinant human erythropoietin (r-HuEPO) is a purified glycoprotein, produced from mammalian cells into which the gene coding for human erythropoietin has been inserted.
EPO 5000iu
£279.00Price